Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Fleury S.A.

Fleury S.A. (FLRY3.SA)

Industry: Medical - Diagnostics & Research Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $27.27 — $57.89
Selected (Average) $42.10
Upside to Live 172.87%
Full Range Fair Value
Range (Low - High) $33.22 — $86.99
Selected (Average) $54.06
Upside to Live 250.38%
Live Price $15.43

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
QIA.DE 19 Qiagen N.V. 2,432 23.67 20.37 12.62 11.54 20.06 19.52
MEDP 20 Medpace Holdings, 2,358 34.47 26.86 28.39 22.62 26.07 22.80
DASA3.SA 21 Diagnósticos da A 2,277 - - 3.95 3.15 5.84 6.20
HLS.AX 22 Healius Limited 2,041 - - - - - 32.34
RDNT 23 RadNet, Inc. 1,970 - - 28.09 26.96 61.49 105.52
4544.T 24 H.U. Group Holding 1,574 133.25 133.25 8.55 7.90 61.88 91.37
300244.SZ 25 Dian Diagnostics G 1,491 - - 20.46 25.74 16.43 -
FLRY3.SA 26 Fleury S.A. 1,462 14.65 11.43 6.25 4.99 9.75 9.48
SHC 27 Sotera Health Comp 1,150 80.62 80.62 15.11 14.35 14.50 16.81
2268.HK 28 WuXi XDC Cayman In 1,119 25.83 25.83 23.87 23.87 16.20 26.58
603108.SS 29 Shanghai Runda Med 1,051 - - 34.56 39.91 98.44 270.99
ACL.AX 30 Australian Clinica 947 8.81 8.81 3.70 3.70 1.36 1.80
4694.T 31 BML, Inc. 935 20.12 18.61 3.72 3.44 6.05 6.52
300347.SZ 32 Hangzhou Tigermed 931 81.58 99.25 39.24 36.22 74.45 416.09
GH 33 Guardant Health, I 903 - - - - - -
NEOG 34 Neogen Corporation 887 - - - - - 614.66

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple24.7523.1013.8612.9416.3222.80
Full Range Median Multiple30.1526.3517.7818.4818.2526.58
Industry Multiple51.0451.7018.5218.2833.56125.48
Market Implied Multiple14.0110.936.084.869.499.23
Company (FLRY3.SA) Multiple14.6511.436.254.999.759.48
(*) Net Income / EBITDA / Revenue109139414518265273
Winsorized Enterprise ValueN/AN/A5,7446,7094,3316,223
Full Range Median Enterprise ValueN/AN/A7,3699,5824,8437,255
(-) Net Debt995995995995995995
Winsorized Equity Value2,6923,2204,7485,7143,3365,228
Full Range Median Equity Value3,2793,6736,3748,5873,8486,260
(/) Shares Outstanding999999999999
Winsorized Fair Value$27.27$32.62$48.10$57.89$33.79$52.96
Full Range Median Fair Value$33.22$37.20$64.57$86.99$38.98$63.42
Current Price$15.43$15.43$15.43$15.43$15.43$15.43
Upside / Downside76.71%111.41%211.75%275.16%118.99%243.23%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$19.09$22.83$33.67$40.52$23.65$37.07
Buy / Don't BuyBUYBUYBUYBUYBUYBUY